Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • usfda

    Tag: usfda

    You Searched For "usfda"
    GSK ovarian cancer drug Zejula gets USFDA nod for wider use

    GSK ovarian cancer drug Zejula gets USFDA nod for wider use

    Medical Dialogues Bureau24 Oct 2019 10:00 AM IST
    Zejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Dr Reddys recalls Ranitidine products in US over cancer-causing impurity

    Medical Dialogues Bureau24 Oct 2019 9:30 AM IST
    This recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
    No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA

    No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA

    Medical Dialogues Bureau24 Oct 2019 9:20 AM IST
    Early tests of alternatives to over-the-counter ranitidine, such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec show no NDMA, the agency said.New...
    Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

    Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC

    Medical Dialogues Bureau22 Oct 2019 9:50 AM IST
    Roche, in its recent release, in 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for Tecentriq in...
    Sanofi pulls popular heartburn drug Zantac in US, Canada

    Sanofi pulls popular heartburn drug Zantac in US, Canada

    Medical Dialogues Bureau21 Oct 2019 9:30 AM IST
    In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and...
    Mylan moves application with DCGI to launch new TB drug Pretomanid in India

    Mylan moves application with DCGI to launch new TB drug Pretomanid in India

    Medical Dialogues Bureau16 Oct 2019 4:10 PM IST
    "We have submitted the new drug application to the office of DCGI. We are in an advanced stage of discussion and are working with the office of...
    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    Farhat Nasim14 Oct 2019 1:13 PM IST
    New Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...
    Cadila Healthcare largest API manufacturing site clears USFDA inspection

    Cadila Healthcare largest API manufacturing site clears USFDA inspection

    Medical Dialogues Bureau12 Oct 2019 11:41 AM IST
    The US Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredients (API) manufacturing facility at Dabhasa from...
    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Medical Dialogues Bureau11 Oct 2019 10:00 AM IST
    "The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Medical Dialogues Bureau11 Oct 2019 9:15 AM IST
    Torrent Pharma does not believe that the warning letter will have an impact on the disruption of supplies or the existing revenues from operations of...
    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Medical Dialogues Bureau10 Oct 2019 11:34 AM IST
    Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Colesevelam Hydrochloride tablets,...
    Galderma wins USFDA nod for AKLIEF Cream to treat acne

    Galderma wins USFDA nod for AKLIEF Cream to treat acne

    Medical Dialogues Bureau10 Oct 2019 9:30 AM IST
    New Delhi: Galderma, announced recently that the U.S. Food and Drug Administration (USFDA) has approved AKLIEF (trifarotene) Cream, 0.005% for the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok